On March 17, 2023 VerImmune, Inc. ("VerImmune"), an innovative biotechnology company leading the way in developing virus-inspired particle modalities for cancer treatment is reported the publication of scientific abstracts for an upcoming Oral presentation at the 35th International Papillomavirus Conference taking place April 17-21 in Washington DC as well as a Poster presentation at the American Associate for Cancer Research Annual 2023 Meeting, taking place April 14-19 in Orlando, Florida (Press release, VerImmune, MAR 17, 2023, View Source [SID1234628993]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details for the Oral and Poster presentations are as follows:
American Associate for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting
Published Abstract Number: 1854
Title: CANCER TREATMENT UTILIZING VIRUS-INSPIRED PARTICLES FOR THE REDIRECTION OF IMMUNE MEMORY
Session Category: Immunology
Session Title: Immunomodulatory Agents and Interventions 2
Session Date and Time: Monday Apr 17, 2023 9:00 AM – 12:30 PM
Location: Poster Section 24
Poster Board Number: 26
35th International Papillomavirus Conference
Title: REDIRECTING PRE-EXISTING VIRAL IMMUNITY TOWARDS CANCERS VIA MURINE PAPILLOMAVIRUS T=1 VIRUS-INSPIRED PARTICLES (VIPS)
Session Name: BASIC SCIENCE ORAL: IMMUNOLOGY & VACCINES
Session Type: Basic Science Oral Abstracts Session
Session Date and time: April 21st 2023; 08:00 – 09:30
Location Room 207A